Published 2003 | Version v1
Publication

Autologous Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023